Biosimilars: What We Learned in 2023

Sponsored by: Akin Gump Strauss Hauer & Feld LLP


Ken Dow is Senior Vice President, General Counsel at Century Therapeutics. Prior to joining Century, he was Vice President, Pharmaceutical Patent Strategy in the Johnson & Johnson Law Department where he was responsible for pre-litigation planning and strategy concerning the patent portfolio for the pharmaceutical sector. Before that, he was Vice President, Patent Law at Janssen Biotech, Inc., a subsidiary of Johnson & Johnson, where he was a member of the research management board and was responsible for overseeing legal matters for the oncology and immunology therapeutic areas, including patent opinions, litigation, preparation, and prosecution, as well as licensing and transactional matters. Ken received his BS in Pharmacy from the State University of New York at Buffalo and his JD from St. John's University. Ken was recently the chair of the Biotechnology Innovation Organization IP Counsels Committee.

Dr. Matthew Pearson litigates patent cases about pharmaceuticals, chemistry and biology, with a particular focus on biologics and antibody technology. In his work as a scientist, he focused on the mechanism and three-dimensional molecular structures of proteins using x-ray crystallography. This scientific background has allowed Matthew to successfully litigate major patent disputes involving biologics, an extremely competitive and technically complex field. His experience as a scientist is critical to designing effective case strategy and in establishing credibility with the scientists who work for his clients.  

Dr. Jonathan Underwood is experienced in all phases of patent infringement litigation, including ANDA litigation, at the trial and appellate level. He defends clients in patent infringement suits, and asserts clients’ patent rights. Jon also counsels clients on strategic IP decisions. Jon’s experience includes representing clients in litigation before the U.S.P.T.O. in inter partes review proceedings. Jon draws on his experience as a post-doctoral research chemist, college educator, and United States District Court judicial clerk to develop clear, winning strategies that resound with fact-finders who lack technical expertise.